{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T23:56:45Z","timestamp":1790726205980,"version":"4.1.0"},"reference-count":86,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2026,3,24]],"date-time":"2026-03-24T00:00:00Z","timestamp":1774310400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,3,24]],"date-time":"2026-03-24T00:00:00Z","timestamp":1774310400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/100000062","name":"U.S. Department of Health & Human Services | NIH | National Institute of Diabetes and Digestive and Kidney Diseases","doi-asserted-by":"publisher","award":["R01DK127081"],"award-info":[{"award-number":["R01DK127081"]}],"id":[{"id":"10.13039\/100000062","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000062","name":"U.S. Department of Health & Human Services | NIH | National Institute of Diabetes and Digestive and Kidney Diseases","doi-asserted-by":"publisher","award":["R01DK131175"],"award-info":[{"award-number":["R01DK131175"]}],"id":[{"id":"10.13039\/100000062","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000062","name":"U.S. Department of Health & Human Services | NIH | National Institute of Diabetes and Digestive and Kidney Diseases","doi-asserted-by":"publisher","award":["U54DK104310"],"award-info":[{"award-number":["U54DK104310"]}],"id":[{"id":"10.13039\/100000062","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000062","name":"U.S. Department of Health & Human Services | NIH | National Institute of Diabetes and Digestive and Kidney Diseases","doi-asserted-by":"publisher","award":["F31DK136335"],"award-info":[{"award-number":["F31DK136335"]}],"id":[{"id":"10.13039\/100000062","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Prostate Cancer Prostatic Dis"],"published-print":{"date-parts":[[2026,10]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Purpose<\/jats:title>\n                    <jats:p>Lower urinary tract symptoms (LUTS) can result from several conditions, including but not limited to benign prostatic hyperplasia, diabetes, stress urinary incontinence, and metabolic syndrome. In 2011, it was estimated that nearly 2 billion people (45.2% of the world population) experience one or more LUTS. To date, there is no single underlying mechanism identified in lower urinary tract symptoms or the associated conditions. However, a recent body of evidence has demonstrated that mitochondrial dysfunction may contribute to conditions associated with LUTS. Furthermore, patients with inherited mitochondrial disease exhibit lower urinary tract symptoms at rates above the general population. Given that mitochondrial dysfunction is an under-investigated area of urinary disease research, this review aims to summarize the existing literature in the field.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>PubMed was used as the primary database for literature search. Keywords included \u201clower urinary tract symptoms\u201d, \u201cmitochondria\u201d, \u201curinary dysfunction\u201d; additionally, once identified, further disease-specific searches were performed (e.g., \u201curinary dysfunction in type 1 diabetes\u201d). Studies published earlier than August 2025 were included, and a specific focus was placed on clinical or human studies. Urologic conditions lacking at least three publications investigating mitochondrial dysfunction were not included; studies examining mitochondrial dysfunction in urologic cancers were also outside the scope of this review.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results and conclusions<\/jats:title>\n                    <jats:p>Mitochondrial dysfunction is a potential novel intersection of diseases associated with LUTS, including aging, metabolic syndrome, diabetes, stress urinary incontinence, benign prostatic hyperplasia, and overactive bladder. While initial studies are promising, more investment into identifying underlying mechanisms and new potential treatments is needed. Additionally, as mitochondrial modulators undergo trial as treatments in other conditions, careful consideration should be given to their potential as treatments for LUTS.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1038\/s41391-026-01097-5","type":"journal-article","created":{"date-parts":[[2026,3,24]],"date-time":"2026-03-24T05:48:50Z","timestamp":1774331330000},"page":"728-734","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["Mitochondrial dysfunction in urologic disease"],"prefix":"10.1038","volume":"29","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-8936-5991","authenticated-orcid":false,"given":"Alexis E.","family":"Adrian","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0004-0680-2730","authenticated-orcid":false,"given":"Natalie J.","family":"Boucher","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0755-0772","authenticated-orcid":false,"given":"Kevin T.","family":"McVary","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Donald B.","family":"DeFranco","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9807-2090","authenticated-orcid":false,"given":"William A.","family":"Ricke","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,3,24]]},"reference":[{"key":"1097_CR1","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1038\/s41392-024-02044-3","volume":"10","author":"H Wen","year":"2025","unstructured":"Wen H, Deng H, Li B, Chen J, Zhu J, Zhang X, et al. Mitochondrial diseases: from molecular mechanisms to therapeutic advances. Signal Transduct Target Ther. 2025;10:9.","journal-title":"Signal Transduct Target Ther"},{"key":"1097_CR2","doi-asserted-by":"publisher","first-page":"546","DOI":"10.1038\/s42255-023-00783-1","volume":"5","author":"AS Monzel","year":"2023","unstructured":"Monzel AS, Enriquez JA, Picard M. Multifaceted mitochondria: moving mitochondrial science beyond function and dysfunction. Nat Metab. 2023;5:546\u201362.","journal-title":"Nat Metab"},{"key":"1097_CR3","doi-asserted-by":"publisher","first-page":"124","DOI":"10.1038\/s41392-024-01839-8","volume":"9","author":"Y Zong","year":"2024","unstructured":"Zong Y, Li H, Liao P, Chen L, Pan Y, Zheng Y, et al. Mitochondrial dysfunction: mechanisms and advances in therapy. Signal Transduct Target Ther. 2024;9:124.","journal-title":"Signal Transduct Target Ther"},{"key":"1097_CR4","doi-asserted-by":"publisher","first-page":"1015","DOI":"10.1146\/annurev.bi.54.070185.005055","volume":"54","author":"Y Hatefi","year":"1985","unstructured":"Hatefi Y. The mitochondrial electron transport and oxidative phosphorylation system. Annu Rev Biochem. 1985;54:1015\u201369.","journal-title":"Annu Rev Biochem"},{"key":"1097_CR5","doi-asserted-by":"publisher","first-page":"457","DOI":"10.1038\/290457a0","volume":"290","author":"S Anderson","year":"1981","unstructured":"Anderson S, Bankier AT, Barrell BG, de Bruijn MH, Coulson AR, Drouin J, et al. Sequence and organization of the human mitochondrial genome. Nature. 1981;290:457\u201365.","journal-title":"Nature"},{"key":"1097_CR6","doi-asserted-by":"publisher","first-page":"695","DOI":"10.1146\/annurev.bi.43.070174.003403","volume":"43","author":"H Kasamatsu","year":"1974","unstructured":"Kasamatsu H, Vinograd J. Replication of circular DNA in eukaryotic cells. Annu Rev Biochem. 1974;43:695\u2013719.","journal-title":"Annu Rev Biochem"},{"key":"1097_CR7","doi-asserted-by":"publisher","first-page":"592","DOI":"10.1038\/314592a0","volume":"314","author":"A Chomyn","year":"1985","unstructured":"Chomyn A, Mariottini P, Cleeter MW, Ragan CI, Matsuno-Yagi A, Hatefi Y, et al. Six unidentified reading frames of human mitochondrial DNA encode components of the respiratory-chain NADH dehydrogenase. Nature. 1985;314:592\u20137.","journal-title":"Nature"},{"key":"1097_CR8","doi-asserted-by":"publisher","first-page":"614","DOI":"10.1126\/science.3764430","volume":"234","author":"A Chomyn","year":"1986","unstructured":"Chomyn A, Cleeter MW, Ragan CI, Riley M, Doolittle RF, Attardi G. URF6, last unidentified reading frame of human mtDNA, codes for an NADH dehydrogenase subunit. Science. 1986;234:614\u20138.","journal-title":"Science"},{"key":"1097_CR9","doi-asserted-by":"publisher","first-page":"327","DOI":"10.1006\/geno.1994.1391","volume":"22","author":"M Tanaka","year":"1994","unstructured":"Tanaka M, Ozawa T. Strand asymmetry in human mitochondrial DNA mutations. Genomics. 1994;22:327\u201335.","journal-title":"Genomics"},{"key":"1097_CR10","doi-asserted-by":"publisher","first-page":"689","DOI":"10.1002\/em.21886","volume":"55","author":"H Sampath","year":"2014","unstructured":"Sampath H. Oxidative DNA damage in disease-insights gained from base excision repair glycosylase-deficient mouse models. Environ Mol Mutagen. 2014;55:689\u2013703.","journal-title":"Environ Mol Mutagen"},{"key":"1097_CR11","doi-asserted-by":"publisher","first-page":"1583","DOI":"10.1091\/mbc.e02-07-0399","volume":"14","author":"N Garrido","year":"2003","unstructured":"Garrido N, Griparic L, Jokitalo E, Wartiovaara J, van der Bliek AM, Spelbrink JN. Composition and dynamics of human mitochondrial nucleoids. Mol Biol Cell. 2003;14:1583\u201396.","journal-title":"Mol Biol Cell"},{"key":"1097_CR12","doi-asserted-by":"publisher","first-page":"419","DOI":"10.1007\/978-1-62703-739-6_31","volume":"1105","author":"A Furda","year":"2014","unstructured":"Furda A, Santos JH, Meyer JN, Van Houten B. Quantitative PCR-based measurement of nuclear and mitochondrial DNA damage and repair in mammalian cells. Methods Mol Biol. 2014;1105:419\u201337.","journal-title":"Methods Mol Biol"},{"key":"1097_CR13","doi-asserted-by":"publisher","first-page":"2706","DOI":"10.1073\/pnas.85.8.2706","volume":"85","author":"R Adelman","year":"1988","unstructured":"Adelman R, Saul RL, Ames BN. Oxidative damage to DNA: relation to species metabolic rate and life span. Proc Natl Acad Sci USA. 1988;85:2706\u20138.","journal-title":"Proc Natl Acad Sci USA"},{"key":"1097_CR14","doi-asserted-by":"publisher","first-page":"383","DOI":"10.1016\/j.mad.2008.03.002","volume":"129","author":"NM Druzhyna","year":"2008","unstructured":"Druzhyna NM, Wilson GL, LeDoux SP, Mitochondrial DNA. repair in aging and disease. Mech Ageing Dev. 2008;129:383\u201390.","journal-title":"Mech Ageing Dev"},{"key":"1097_CR15","doi-asserted-by":"publisher","first-page":"514","DOI":"10.1073\/pnas.94.2.514","volume":"94","author":"FM Yakes","year":"1997","unstructured":"Yakes FM, Van Houten B, Mitochondrial DNA. damage is more extensive and persists longer than nuclear DNA damage in human cells following oxidative stress. Proc Natl Acad Sci USA. 1997;94:514\u20139.","journal-title":"Proc Natl Acad Sci USA"},{"key":"1097_CR16","doi-asserted-by":"publisher","first-page":"1401","DOI":"10.1016\/j.bbabio.2015.05.015","volume":"1847","author":"MJ Keogh","year":"2015","unstructured":"Keogh MJ, Chinnery PF, Mitochondrial DNA. mutations in neurodegeneration. Biochim Biophys Acta. 2015;1847:1401\u201311.","journal-title":"Biochim Biophys Acta"},{"key":"1097_CR17","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-018-30255-6","volume":"8","author":"GJ Tranah","year":"2018","unstructured":"Tranah GJ, Katzman SM, Lauterjung K, Yaffe K, Manini TM, Kritchevsky S, et al. Mitochondrial DNA m.3243A>G heteroplasmy affects multiple aging phenotypes and risk of mortality. Sci Rep. 2018;8:11887.","journal-title":"Sci Rep"},{"key":"1097_CR18","doi-asserted-by":"publisher","first-page":"243","DOI":"10.1038\/s41574-021-00626-7","volume":"18","author":"JA Amorim","year":"2022","unstructured":"Amorim JA, Coppotelli G, Rolo AP, Palmeira CM, Ross JM, Sinclair DA. Mitochondrial and metabolic dysfunction in ageing and age-related diseases. Nat Rev Endocrinol. 2022;18:243\u201358.","journal-title":"Nat Rev Endocrinol"},{"key":"1097_CR19","doi-asserted-by":"publisher","first-page":"825","DOI":"10.1007\/s11357-024-01355-1","volume":"47","author":"Q Tian","year":"2025","unstructured":"Tian Q, Zweibaum DA, Qian Y, Oppong RF, Pilling LC, Casanova F, et al. Mitochondrial DNA copy number associated dementia risk by somatic mutations and frailty. Geroscience. 2025;47:825\u201335.","journal-title":"Geroscience"},{"key":"1097_CR20","doi-asserted-by":"publisher","first-page":"823","DOI":"10.1111\/j.1471-4159.1990.tb02325.x","volume":"54","author":"AH Schapira","year":"1990","unstructured":"Schapira AH, Cooper JM, Dexter D, Clark JB, Jenner P, Marsden CD. Mitochondrial complex I deficiency in Parkinson\u2019s disease. J Neurochem. 1990;54:823\u20137.","journal-title":"J Neurochem"},{"key":"1097_CR21","doi-asserted-by":"publisher","first-page":"3","DOI":"10.3390\/biom12030427","volume":"12","author":"BR Walker","year":"2022","unstructured":"Walker BR, Moraes CT. Nuclear-mitochondrial interactions. Biomolecules. 2022;12:3.","journal-title":"Biomolecules"},{"key":"1097_CR22","doi-asserted-by":"publisher","first-page":"167803","DOI":"10.1016\/j.bbadis.2025.167803","volume":"1871","author":"JP Moura","year":"2025","unstructured":"Moura JP, Oliveira PJ, Urbano AM. Mitochondria: an overview of their origin, genome, architecture, and dynamics. Biochim Biophys Acta Mol Basis Dis. 2025;1871:167803.","journal-title":"Biochim Biophys Acta Mol Basis Dis"},{"key":"1097_CR23","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1093\/nar\/28.1.27","volume":"28","author":"M Kanehisa","year":"2000","unstructured":"Kanehisa M, Goto S. KEGG: kyoto encyclopedia of genes and genomes. Nucleic Acids Res. 2000;28:27\u201330.","journal-title":"Nucleic Acids Res"},{"key":"1097_CR24","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-019-41933-4","volume":"9","author":"VK Jaeger","year":"2019","unstructured":"Jaeger VK, Lebrecht D, Nicholson AG, Wells A, Bhayani H, Gazdhar A, et al. Mitochondrial DNA mutations and respiratory chain dysfunction in idiopathic and connective tissue disease-related lung fibrosis. Sci Rep. 2019;9:5500.","journal-title":"Sci Rep"},{"key":"1097_CR25","doi-asserted-by":"publisher","first-page":"1341","DOI":"10.1080\/15548627.2015.1061849","volume":"11","author":"RA Sinha","year":"2015","unstructured":"Sinha RA, Singh BK, Zhou J, Wu Y, Farah BL, Ohba K, et al. Thyroid hormone induction of mitochondrial activity is coupled to mitophagy via ROS-AMPK-ULK1 signaling. Autophagy. 2015;11:1341\u201357.","journal-title":"Autophagy"},{"key":"1097_CR26","doi-asserted-by":"publisher","first-page":"615","DOI":"10.1172\/JCI27794","volume":"116","author":"BN Finck","year":"2006","unstructured":"Finck BN, Kelly DP. PGC-1 coactivators: inducible regulators of energy metabolism in health and disease. J Clin Invest. 2006;116:615\u201322.","journal-title":"J Clin Invest"},{"key":"1097_CR27","doi-asserted-by":"publisher","first-page":"367","DOI":"10.1038\/sj.onc.1208207","volume":"24","author":"S Elchuri","year":"2005","unstructured":"Elchuri S, Oberley TD, Qi W, Eisenstein RS, Jackson Roberts L, Van Remmen H, et al. CuZnSOD deficiency leads to persistent and widespread oxidative damage and hepatocarcinogenesis later in life. Oncogene. 2005;24:367\u201380.","journal-title":"Oncogene"},{"key":"1097_CR28","doi-asserted-by":"publisher","first-page":"561","DOI":"10.1038\/nature01819","volume":"424","author":"CA Neumann","year":"2003","unstructured":"Neumann CA, Krause DS, Carman CV, Das S, Dubey DP, Abraham JL, et al. Essential role for the peroxiredoxin Prdx1 in erythrocyte antioxidant defence and tumour suppression. Nature. 2003;424:561\u20135.","journal-title":"Nature"},{"key":"1097_CR29","doi-asserted-by":"publisher","first-page":"12920","DOI":"10.1073\/pnas.231472998","volume":"98","author":"J Moskovitz","year":"2001","unstructured":"Moskovitz J, Bar-Noy S, Williams WM, Requena J, Berlett BS, Stadtman ER. Methionine sulfoxide reductase (MsrA) is a regulator of antioxidant defense and lifespan in mammals. Proc Natl Acad Sci USA. 2001;98:12920\u20135.","journal-title":"Proc Natl Acad Sci USA"},{"key":"1097_CR30","doi-asserted-by":"publisher","first-page":"314","DOI":"10.1016\/j.freeradbiomed.2015.05.036","volume":"88","author":"H Zhang","year":"2015","unstructured":"Zhang H, Davies KJA, Forman HJ. Oxidative stress response and Nrf2 signaling in aging. Free Radic Biol Med. 2015;88:314\u201336.","journal-title":"Free Radic Biol Med"},{"key":"1097_CR31","doi-asserted-by":"publisher","first-page":"745","DOI":"10.1038\/s41556-018-0124-1","volume":"20","author":"JB Spinelli","year":"2018","unstructured":"Spinelli JB, Haigis MC. The multifaceted contributions of mitochondria to cellular metabolism. Nat Cell Biol. 2018;20:745\u201354.","journal-title":"Nat Cell Biol"},{"key":"1097_CR32","doi-asserted-by":"crossref","unstructured":"Makinde E, Ma L, Mellick GD, Feng Y. Mitochondrial modulators: the defender. Biomolecules. 2023;13:226.","DOI":"10.3390\/biom13020226"},{"key":"1097_CR33","doi-asserted-by":"publisher","first-page":"1776","DOI":"10.1172\/JCI104637","volume":"41","author":"R Luft","year":"1962","unstructured":"Luft R, Ikkos D, Palmieri G, Ernster L, Afzelius B. A case of severe hypermetabolism of nonthyroid origin with a defect in the maintenance of mitochondrial respiratory control: a correlated clinical, biochemical, and morphological study. J Clin Invest. 1962;41:1776\u2013804.","journal-title":"J Clin Invest"},{"key":"1097_CR34","doi-asserted-by":"publisher","first-page":"1 23 1","DOI":"10.1002\/0471250953.bi0123s44","volume":"44","author":"MT Lott","year":"2013","unstructured":"Lott MT, Leipzig JN, Derbeneva O, Xie HM, Chalkia D, Sarmady M, et al. mtDNA variation and analysis using mitomap and mitomaster. Curr Protoc Bioinformatics. 2013;44:1 23 1\u20136.","journal-title":"Curr Protoc Bioinformatics"},{"key":"1097_CR35","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1016\/j.ymgme.2015.06.004","volume":"116","author":"AW El-Hattab","year":"2015","unstructured":"El-Hattab AW, Adesina AM, Jones J, Scaglia F. MELAS syndrome: clinical manifestations, pathogenesis, and treatment options. Mol Genet Metab. 2015;116:4\u201312.","journal-title":"Mol Genet Metab"},{"key":"1097_CR36","doi-asserted-by":"publisher","first-page":"976","DOI":"10.1001\/archneurol.2010.174","volume":"67","author":"T Parsons","year":"2010","unstructured":"Parsons T, Weimer L, Engelstad K, Linker A, Battista V, Wei Y, et al. Autonomic symptoms in carriers of the m.3243\u2009A\u2009>\u2009G mitochondrial DNA mutation. Arch Neurol. 2010;67:976\u20139.","journal-title":"Arch Neurol"},{"key":"1097_CR37","doi-asserted-by":"publisher","first-page":"2253","DOI":"10.1002\/nau.24479","volume":"39","author":"C Feeney","year":"2020","unstructured":"Feeney C, Gorman G, Stefanetti R, McFarland R, Turnbull D, Harding C, et al. Lower urinary tract dysfunction in adult patients with mitochondrial disease. Neurourol Urodyn. 2020;39:2253\u201363.","journal-title":"Neurourol Urodyn"},{"key":"1097_CR38","doi-asserted-by":"publisher","first-page":"1111","DOI":"10.1111\/ene.13952","volume":"26","author":"OV Poole","year":"2019","unstructured":"Poole OV, Uchiyama T, Skorupinska I, Skorupinska M, Germain L, Kozyra D, et al. Urogenital symptoms in mitochondrial disease: overlooked and undertreated. Eur J Neurol. 2019;26:1111\u201320.","journal-title":"Eur J Neurol"},{"key":"1097_CR39","doi-asserted-by":"publisher","first-page":"230","DOI":"10.1016\/j.urology.2021.12.023","volume":"164","author":"V Kucherov","year":"2022","unstructured":"Kucherov V, Truong H, Raab C, Hagerty JA. Urologic presentations and management options in pediatric mitochondrial disease. Urology. 2022;164:230\u20137.","journal-title":"Urology"},{"key":"1097_CR40","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.ecl.2013.09.009","volume":"43","author":"SL Samson","year":"2014","unstructured":"Samson SL, Garber AJ. Metabolic syndrome. Endocrinol Metab Clin North Am. 2014;43:1\u201323.","journal-title":"Endocrinol Metab Clin North Am"},{"key":"1097_CR41","doi-asserted-by":"publisher","first-page":"165838","DOI":"10.1016\/j.bbadis.2020.165838","volume":"1866","author":"P Prasun","year":"2020","unstructured":"Prasun P. Mitochondrial dysfunction in metabolic syndrome. Biochim Biophys Acta Mol Basis Dis. 2020;1866:165838.","journal-title":"Biochim Biophys Acta Mol Basis Dis"},{"key":"1097_CR42","doi-asserted-by":"crossref","unstructured":"Masenga SK, Kabwe LS, Chakulya M, Kirabo A. Mechanisms of oxidative stress in metabolic syndrome. Int J Mol Sci. 2023;24:7898.","DOI":"10.3390\/ijms24097898"},{"key":"1097_CR43","doi-asserted-by":"publisher","first-page":"860","DOI":"10.1038\/nature05485","volume":"444","author":"GS Hotamisligil","year":"2006","unstructured":"Hotamisligil GS. Inflammation and metabolic disorders. Nature. 2006;444:860\u20137.","journal-title":"Nature"},{"key":"1097_CR44","doi-asserted-by":"publisher","first-page":"674","DOI":"10.1016\/j.urology.2013.03.047","volume":"82","author":"YW Park","year":"2013","unstructured":"Park YW, Kim SB, Kwon H, Kang HC, Cho K, Lee KI, et al. The relationship between lower urinary tract symptoms\/benign prostatic hyperplasia and the number of components of metabolic syndrome. Urology. 2013;82:674\u20139.","journal-title":"Urology"},{"key":"1097_CR45","doi-asserted-by":"publisher","first-page":"68","DOI":"10.1111\/j.1757-5672.2011.00115.x","volume":"4","author":"H Ito","year":"2012","unstructured":"Ito H, Yoshiyasu T, Yamaguchi O, Yokoyama O. Male lower urinary tract symptoms: hypertension as a risk factor for storage symptoms, but not voiding symptoms. Low Urin Tract Symptoms. 2012;4:68\u201372.","journal-title":"Low Urin Tract Symptoms"},{"key":"1097_CR46","doi-asserted-by":"publisher","first-page":"32","DOI":"10.1111\/luts.12046","volume":"7","author":"EC Hwang","year":"2015","unstructured":"Hwang EC, Kim SO, Nam DH, Yu HS, Hwang I, Jung SI, et al. Men with hypertension are more likely to have severe lower urinary tract symptoms and large prostate volume. Low Urin Tract Symptoms. 2015;7:32\u20136.","journal-title":"Low Urin Tract Symptoms"},{"key":"1097_CR47","doi-asserted-by":"publisher","first-page":"273","DOI":"10.1038\/pcan.2011.69","volume":"15","author":"C Chong","year":"2012","unstructured":"Chong C, Fong L, Lai R, Koh YT, Lau WK, Hartman M, et al. The prevalence of lower urinary tract symptoms and treatment-seeking behaviour in males over 40 years in Singapore: a community-based study. Prostate Cancer Prostatic Dis. 2012;15:273\u20137.","journal-title":"Prostate Cancer Prostatic Dis"},{"key":"1097_CR48","doi-asserted-by":"publisher","first-page":"244","DOI":"10.1016\/j.diff.2011.04.005","volume":"82","author":"MR Freeman","year":"2011","unstructured":"Freeman MR, Solomon KR. Cholesterol and benign prostate disease. Differentiation. 2011;82:244\u201352.","journal-title":"Differentiation"},{"key":"1097_CR49","doi-asserted-by":"publisher","first-page":"223","DOI":"10.3109\/13685538.2014.967671","volume":"17","author":"Q He","year":"2014","unstructured":"He Q, Wang H, Yue Z, Yang L, Tian J, Liu G, et al. Waist circumference and risk of lower urinary tract symptoms: a meta-analysis. Aging Male. 2014;17:223\u20139.","journal-title":"Aging Male"},{"key":"1097_CR50","doi-asserted-by":"publisher","first-page":"1360","DOI":"10.1002\/nau.20892","volume":"29","author":"MG Kirby","year":"2010","unstructured":"Kirby MG, Wagg A, Cardozo L, Chapple C, Castro-Diaz D, de Ridder D, et al. Overactive bladder: is there a link to the metabolic syndrome in men?. Neurourol Urodyn. 2010;29:1360\u20134.","journal-title":"Neurourol Urodyn"},{"key":"1097_CR51","doi-asserted-by":"publisher","first-page":"397","DOI":"10.1111\/iju.14476","volume":"28","author":"A Otsubo","year":"2021","unstructured":"Otsubo A, Miyata Y, Matsuo T, Mukae Y, Mitsunari K, Ohba K, et al. Excessive accumulation of visceral fat is associated with lower urinary symptoms including overactive bladder in female patients. Int J Urol. 2021;28:397\u2013403.","journal-title":"Int J Urol"},{"key":"1097_CR52","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1038\/pcan.2015.43","volume":"19","author":"Q He","year":"2016","unstructured":"He Q, Wang Z, Liu G, Daneshgari F, MacLennan GT, Gupta S. Metabolic syndrome, inflammation and lower urinary tract symptoms: possible translational links. Prostate Cancer Prostatic Dis. 2016;19:7\u201313.","journal-title":"Prostate Cancer Prostatic Dis"},{"key":"1097_CR53","doi-asserted-by":"publisher","first-page":"1123","DOI":"10.1002\/pros.22662","volume":"73","author":"M Gharaee-Kermani","year":"2013","unstructured":"Gharaee-Kermani M, Rodriguez-Nieves JA, Mehra R, Vezina CA, Sarma AV, Macoska JA. Obesity-induced diabetes and lower urinary tract fibrosis promote urinary voiding dysfunction in a mouse model. Prostate. 2013;73:1123\u201333.","journal-title":"Prostate"},{"key":"1097_CR54","doi-asserted-by":"publisher","first-page":"e70014","DOI":"10.1111\/1753-0407.70014","volume":"16","author":"R Weinberg Sibony","year":"2024","unstructured":"Weinberg Sibony R, Segev O, Dor S, Raz I. Overview of oxidative stress and inflammation in diabetes. J Diabetes. 2024;16:e70014.","journal-title":"J Diabetes"},{"key":"1097_CR55","doi-asserted-by":"publisher","first-page":"245","DOI":"10.1016\/j.mito.2019.06.007","volume":"49","author":"P Jezek","year":"2019","unstructured":"Jezek P, Dlaskova A. Dynamic of mitochondrial network, cristae, and mitochondrial nucleoids in pancreatic beta-cells. Mitochondrion. 2019;49:245\u201358.","journal-title":"Mitochondrion"},{"key":"1097_CR56","doi-asserted-by":"publisher","first-page":"266","DOI":"10.3892\/etm.2020.9396","volume":"20","author":"W Sha","year":"2020","unstructured":"Sha W, Hu F, Bu S. Mitochondrial dysfunction and pancreatic islet beta-cell failure (Review). Exp Ther Med. 2020;20:266.","journal-title":"Exp Ther Med"},{"key":"1097_CR57","doi-asserted-by":"publisher","first-page":"1185656","DOI":"10.3389\/fendo.2023.1185656","volume":"14","author":"M Deepa Maheshvare","year":"2023","unstructured":"Deepa Maheshvare M, Raha S, Konig M, Pal D. A pathway model of glucose-stimulated insulin secretion in the pancreatic beta-cell. Front Endocrinol. 2023;14:1185656.","journal-title":"Front Endocrinol"},{"key":"1097_CR58","doi-asserted-by":"publisher","first-page":"615","DOI":"10.1007\/s00125-007-0916-5","volume":"51","author":"C Ling","year":"2008","unstructured":"Ling C, Del Guerra S, Lupi R, Ronn T, Granhall C, Luthman H, et al. Epigenetic regulation of PPARGC1A in human type 2 diabetic islets and effect on insulin secretion. Diabetologia. 2008;51:615\u201322.","journal-title":"Diabetologia"},{"key":"1097_CR59","doi-asserted-by":"publisher","first-page":"1087","DOI":"10.1007\/s00125-009-1319-6","volume":"52","author":"MJ MacDonald","year":"2009","unstructured":"MacDonald MJ, Longacre MJ, Langberg EC, Tibell A, Kendrick MA, Fukao T, et al. Decreased levels of metabolic enzymes in pancreatic islets of patients with type 2 diabetes. Diabetologia. 2009;52:1087\u201391.","journal-title":"Diabetologia"},{"key":"1097_CR60","doi-asserted-by":"publisher","first-page":"267","DOI":"10.1038\/ng1180","volume":"34","author":"VK Mootha","year":"2003","unstructured":"Mootha VK, Lindgren CM, Eriksson KF, Subramanian A, Sihag S, Lehar J, et al. PGC-1alpha-responsive genes involved in oxidative phosphorylation are coordinately downregulated in human diabetes. Nat Genet. 2003;34:267\u201373.","journal-title":"Nat Genet"},{"key":"1097_CR61","doi-asserted-by":"publisher","first-page":"8466","DOI":"10.1073\/pnas.1032913100","volume":"100","author":"ME Patti","year":"2003","unstructured":"Patti ME, Butte AJ, Crunkhorn S, Cusi K, Berria R, Kashyap S, et al. Coordinated reduction of genes of oxidative metabolism in humans with insulin resistance and diabetes: potential role of PGC1 and NRF1. Proc Natl Acad Sci USA. 2003;100:8466\u201371.","journal-title":"Proc Natl Acad Sci USA"},{"key":"1097_CR62","doi-asserted-by":"publisher","first-page":"2944","DOI":"10.2337\/diabetes.51.10.2944","volume":"51","author":"DE Kelley","year":"2002","unstructured":"Kelley DE, He J, Menshikova EV, Ritov VB. Dysfunction of mitochondria in human skeletal muscle in type 2 diabetes. Diabetes. 2002;51:2944\u201350.","journal-title":"Diabetes"},{"key":"1097_CR63","doi-asserted-by":"publisher","first-page":"814","DOI":"10.1002\/nau.20422","volume":"26","author":"N Kebapci","year":"2007","unstructured":"Kebapci N, Yenilmez A, Efe B, Entok E, Demirustu C. Bladder dysfunction in type 2 diabetic patients. Neurourol Urodyn. 2007;26:814\u20139.","journal-title":"Neurourol Urodyn"},{"key":"1097_CR64","doi-asserted-by":"publisher","first-page":"136","DOI":"10.3389\/fphar.2010.00136","volume":"1","author":"S Golbidi","year":"2010","unstructured":"Golbidi S, Laher I. Bladder dysfunction in diabetes mellitus. Front Pharmacol. 2010;1:136.","journal-title":"Front Pharmacol"},{"key":"1097_CR65","doi-asserted-by":"publisher","DOI":"10.1186\/1471-2490-13-12","volume":"13","author":"SK Van Den Eeden","year":"2013","unstructured":"Van Den Eeden SK, Ferrara A, Shan J, Jacobsen SJ, Quinn VP, Haque R, et al. Impact of type 2 diabetes on lower urinary tract symptoms in men: a cohort study. BMC Urol. 2013;13:12.","journal-title":"BMC Urol"},{"key":"1097_CR66","doi-asserted-by":"publisher","first-page":"141","DOI":"10.1016\/j.urology.2017.03.040","volume":"105","author":"CA Tam","year":"2017","unstructured":"Tam CA, Helfand BT, Erickson BA. The relationship between diabetes, diabetes severity, diabetes biomarkers, and the presence of lower urinary tract symptoms: findings from the National Health and Nutrition Examination Survey. Urology. 2017;105:141\u20138.","journal-title":"Urology"},{"key":"1097_CR67","doi-asserted-by":"publisher","first-page":"2170","DOI":"10.2337\/dc18-0255","volume":"41","author":"H Wessells","year":"2018","unstructured":"Wessells H, Braffett BH, Holt SK, Jacobson AM, Kusek JW, Cowie C, et al. Burden of urological complications in men and women with long-standing type 1 diabetes in the diabetes control and complications trial\/epidemiology of diabetes interventions and complications cohort. Diabetes Care. 2018;41:2170\u20137.","journal-title":"Diabetes Care"},{"key":"1097_CR68","doi-asserted-by":"publisher","first-page":"285","DOI":"10.1016\/S0065-2776(08)60490-3","volume":"51","author":"H Kikutani","year":"1992","unstructured":"Kikutani H, Makino S. The murine autoimmune diabetes model: NOD and related strains. Adv Immunol. 1992;51:285\u2013322.","journal-title":"Adv Immunol"},{"key":"1097_CR69","doi-asserted-by":"publisher","first-page":"1559","DOI":"10.4049\/jimmunol.179.3.1559","volume":"179","author":"G Penna","year":"2007","unstructured":"Penna G, Amuchastegui S, Cossetti C, Aquilano F, Mariani R, Giarratana N, et al. Spontaneous and prostatic steroid binding protein peptide-induced autoimmune prostatitis in the nonobese diabetic mouse. J Immunol. 2007;179:1559\u201367.","journal-title":"J Immunol"},{"key":"1097_CR70","doi-asserted-by":"publisher","first-page":"980","DOI":"10.1002\/pros.23809","volume":"79","author":"LM Aaron-Brooks","year":"2019","unstructured":"Aaron-Brooks LM, Sasaki T, Vickman RE, Wei L, Franco OE, Ji Y, et al. Hyperglycemia and T Cell infiltration are associated with stromal and epithelial prostatic hyperplasia in the nonobese diabetic mouse. Prostate. 2019;79:980\u201393.","journal-title":"Prostate"},{"key":"1097_CR71","doi-asserted-by":"publisher","first-page":"608637","DOI":"10.3389\/fphar.2021.608637","volume":"12","author":"J Wang","year":"2021","unstructured":"Wang J, Dai L, Yue X, Shen C, Li T, Long L, et al. IR-61 improves voiding function via mitochondrial protection in diabetic rats. Front Pharmacol. 2021;12:608637.","journal-title":"Front Pharmacol"},{"key":"1097_CR72","doi-asserted-by":"publisher","first-page":"267","DOI":"10.1016\/S0090-4295(02)02371-3","volume":"61","author":"M Emberton","year":"2003","unstructured":"Emberton M, Andriole GL, de la Rosette J, Djavan B, Hoefner K, Vela Navarrete R, et al. Benign prostatic hyperplasia: a progressive disease of aging men. Urology. 2003;61:267\u201373.","journal-title":"Urology"},{"key":"1097_CR73","doi-asserted-by":"crossref","unstructured":"Adrian AE, Liu TT, Pascal LE, Bauer SR, DeFranco DB, Ricke WA. Aging-related mitochondrial dysfunction is associated with fibrosis in benign prostatic hyperplasia. J Gerontol A Biol Sci Med Sci. 2024;79:glad222.","DOI":"10.1093\/gerona\/glad222"},{"key":"1097_CR74","doi-asserted-by":"crossref","unstructured":"Liu TT, Igarashi T, El-Khoury N, Ihejirika N, Paxton K, Jaumotte J, et al. Benign prostatic hyperplasia nodules in patients treated with celecoxib and\/or finasteride have reduced levels of NADH dehydrogenase [ubiquinone] iron-sulfur protein 3, a mitochondrial protein essential for efficient function of the electron transport chain. Prostate. 2024;84:1309\u201319.","DOI":"10.1002\/pros.24766"},{"key":"1097_CR75","doi-asserted-by":"publisher","first-page":"58","DOI":"10.1002\/pros.23100","volume":"76","author":"P Vital","year":"2016","unstructured":"Vital P, Castro P, Ittmann M. Oxidative stress promotes benign prostatic hyperplasia. Prostate. 2016;76:58\u201367.","journal-title":"Prostate"},{"key":"1097_CR76","doi-asserted-by":"publisher","first-page":"1375","DOI":"10.1021\/acs.jproteome.9b00451","volume":"19","author":"S Thomas","year":"2020","unstructured":"Thomas S, Hao L, DeLaney K, McLean D, Steinke L, Marker PC, et al. Spatiotemporal proteomics reveals the molecular consequences of hormone treatment in a mouse model of lower urinary tract dysfunction. J Proteome Res. 2020;19:1375\u201382.","journal-title":"J Proteome Res"},{"key":"1097_CR77","doi-asserted-by":"publisher","first-page":"446","DOI":"10.1016\/S0090-4295(98)00497-X","volume":"53","author":"RM Levin","year":"1999","unstructured":"Levin RM, Haugaard N, Mogavero L, Leggett RE, Das AK. Biochemical evaluation of obstructive bladder dysfunction in men secondary to BPH: a preliminary report. Urology. 1999;53:446\u201350.","journal-title":"Urology"},{"key":"1097_CR78","doi-asserted-by":"publisher","first-page":"225","DOI":"10.1016\/S0022-5347(05)68011-1","volume":"163","author":"SH Lu","year":"2000","unstructured":"Lu SH, Wei YH, Chang LS, Lin AT, Chen KK, Yang AH. Morphological and morphometric analysis of human detrusor mitochondria with urodynamic correlation after partial bladder outlet obstruction. J Urol. 2000;163:225\u20139.","journal-title":"J Urol"},{"key":"1097_CR79","doi-asserted-by":"publisher","first-page":"161","DOI":"10.1023\/A:1006945732718","volume":"197","author":"CA Nevel-McGarvey","year":"1999","unstructured":"Nevel-McGarvey CA, Rohrmann D, Levin RM, Hudson AP. Mitochondrial and mitochondrial-related nuclear genetic function in rabbit urinary bladder following reversal of outlet obstruction. Mol Cell Biochem. 1999;197:161\u201372.","journal-title":"Mol Cell Biochem"},{"key":"1097_CR80","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-019-12332-0","volume":"10","author":"C Liu","year":"2019","unstructured":"Liu C, Tate T, Batourina E, Truschel ST, Potter S, Adam M, et al. Pparg promotes differentiation and regulates mitochondrial gene expression in bladder epithelial cells. Nat Commun. 2019;10:4589.","journal-title":"Nat Commun"},{"key":"1097_CR81","doi-asserted-by":"publisher","first-page":"111","DOI":"10.5213\/inj.2142224.112","volume":"26","author":"MM de Rijk","year":"2022","unstructured":"de Rijk MM, Wolf-Johnston A, Kullmann AF, Taiclet S, Kanai AJ, Shiva S, et al. Aging-associated changes in oxidative stress negatively impacts the urinary bladder urothelium. Int Neurourol J. 2022;26:111\u20138.","journal-title":"Int Neurourol J"},{"key":"1097_CR82","doi-asserted-by":"publisher","first-page":"e70265","DOI":"10.14814\/phy2.70265","volume":"13","author":"S Hata","year":"2025","unstructured":"Hata S, Shinohara M, Mimata H, Shin T. Ultrastructural analysis of mitochondrial morphology and in the human rhabdosphincter: Insights into urinary incontinence. Physiol Rep. 2025;13:e70265.","journal-title":"Physiol Rep"},{"key":"1097_CR83","doi-asserted-by":"publisher","first-page":"e70009","DOI":"10.1111\/cpr.70009","volume":"58","author":"L Chen","year":"2025","unstructured":"Chen L, Tang J, Zuo X, Li B, Liu C, Hong S, et al. SIRT1 alleviates oxidative stress-induced mitochondrial dysfunction and mitochondria-associated membrane dysregulation in stress urinary incontinence. Cell Prolif. 2025;58:e70009.","journal-title":"Cell Prolif"},{"key":"1097_CR84","doi-asserted-by":"publisher","first-page":"867","DOI":"10.1007\/s00192-009-0871-4","volume":"20","author":"MJ Sun","year":"2009","unstructured":"Sun MJ, Cheng WL, Wei YH, Kuo CL, Sun S, Tsai HD, et al. Low copy number and high 4977 deletion of mitochondrial DNA in uterosacral ligaments are associated with pelvic organ prolapse progression. Int Urogynecol J Pelvic Floor Dysfunct. 2009;20:867\u201372.","journal-title":"Int Urogynecol J Pelvic Floor Dysfunct"},{"key":"1097_CR85","doi-asserted-by":"publisher","first-page":"588","DOI":"10.1016\/j.juro.2012.09.041","volume":"189","author":"EJ Kim","year":"2013","unstructured":"Kim EJ, Chung N, Park SH, Lee KH, Kim SW, Kim JY, et al. Involvement of oxidative stress and mitochondrial apoptosis in the pathogenesis of pelvic organ prolapse. J Urol. 2013;189:588\u201394.","journal-title":"J Urol"},{"key":"1097_CR86","doi-asserted-by":"publisher","first-page":"969","DOI":"10.1016\/j.eururo.2005.12.042","volume":"50","author":"J Rassweiler","year":"2006","unstructured":"Rassweiler J, Teber D, Kuntz R, Hofmann R. Complications of transurethral resection of the prostate (TURP)-incidence, management, and prevention. Eur Urol. 2006;50:969\u201379. discussion 80.","journal-title":"Eur Urol"}],"container-title":["Prostate Cancer and Prostatic Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41391-026-01097-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41391-026-01097-5","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41391-026-01097-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T23:02:27Z","timestamp":1790722947000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41391-026-01097-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,3,24]]},"references-count":86,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2026,10]]}},"alternative-id":["1097"],"URL":"https:\/\/doi.org\/10.1038\/s41391-026-01097-5","relation":{},"ISSN":["1365-7852","1476-5608"],"issn-type":[{"value":"1365-7852","type":"print"},{"value":"1476-5608","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,3,24]]},"assertion":[{"value":"12 December 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 February 2026","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 February 2026","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 March 2026","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Ethics"}}]}}